CN1344539A - Superfine active Chinese medicine powder buccal tablet and its making process - Google Patents
Superfine active Chinese medicine powder buccal tablet and its making process Download PDFInfo
- Publication number
- CN1344539A CN1344539A CN 00124586 CN00124586A CN1344539A CN 1344539 A CN1344539 A CN 1344539A CN 00124586 CN00124586 CN 00124586 CN 00124586 A CN00124586 A CN 00124586A CN 1344539 A CN1344539 A CN 1344539A
- Authority
- CN
- China
- Prior art keywords
- superfine active
- chinese medicine
- buccal tablet
- active powder
- micropowder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Abstract
The buccal tablet made of superfine active Chinese medicine powder contains 15-85 wt% superfine active Chinese medicine powder below 10 microns as well as supplementary material. Its active components may be absorbed through oral mucous membrane, and the baccal tablet has high comprehensive absorption effect and high health care effect. In addition, the present invention also provides the preparation process of the buccal tablet.
Description
The present invention relates to a kind of Chinese patent medicine buccal tablet, relate in particular to a kind of Chinese medicine superfine active powder buccal tablet for the treatment of non-oropharynx class disease and preparation method thereof.
Along with rapid development of economy, the improving constantly of people's living standard, the demand of health promoting product is more and more big, and especially the health care of Chinese patent medicine class is subjected to doting on of consumers in general especially deeply.At present, Chinese medicine superfine active micropowder product is mainly capsule class, existing application for a patent for invention (CN1185968A, a kind of " superfined American ginseng capsule and preparation method thereof " disclosed A61K35/78 A61K 9/48), this superfined American ginseng capsule is made up of glue shell and capsule core material, its capsule core material is the superfined American ginseng about 500 orders, behind the gastro-intestinal digestion Absorption, the absorbance of American Ginseng powder only reaches 10%, so the American Ginseng powder absorbance in this capsule product awaits further raising, and be added with enzyme in its glue shell, in depositing process, might have a negative impact American Ginseng powder; Other has application for a patent for invention (CN1139556A, A61K 35/78 A61J 3/02) discloses in a kind of " ultramicro active ginseng powder and technology of preparing thereof ", this technology is capital equipment with the jet mill, various Radix Ginseng powder are broken into particle mean size less than 5 microns ultramicro active ginseng powder, this product is powdery, and is loosely organized, do not have solid shape and take inconvenience.Such short (being about 5-10 minute) discharges inhomogeneously medicine buccal time, and absorbance only reaches 6%.
Also has application for a patent for invention (CN1133737A, A61K 35/84) a kind of " lucid ganoderma buccal tablets and preparation technology " be provided, described lucid ganoderma buccal tablets earlier by Ganoderma through the ethanol lixiviate, mix with Radix Glycyrrhizae the back, through flooding, collect the lixiviating solution concentrate drying, allocate glycoconjugates and nutrition enhancer then into, its complex manufacturing technology, and its chemical process is big to the active ingredient influence; Also having the Radix Panacis Quinquefolii decoction pieces in the existing commercially available prod, be that Radix Panacis Quinquefolii is thinly sliced buccal in mouth, but this series products exists residual residue many, and active ingredient discharges inhomogeneous, and utilization rate is low, more is difficult to satisfy modern people's allegro life requirement.
The objective of the invention is to overcome the prior art deficiency, a kind of Chinese medicine superfine active powder buccal tablet is provided, but this buccal tablet oral transmucosal absorbs effective active components, comprehensive assimilation effect is better, improves health-care effect significantly.
The present invention also provides the preparation method of this Chinese medicine superfine active powder buccal tablet.
For this reason, the invention provides a kind of Chinese medicine superfine active powder buccal tablet, the Chinese medicine superfine active micropowder that wherein contains 15%-85 weight %, described Chinese medicine superfine active micropowder granularity is below 15 μ m, and preferably controlling particle size is below 10 μ m, and the preferred size scope is about 5-10 μ m, the micropowder process technology feasibility of this particle size range is strong, product biological activity height helps absorbing, and described Chinese medicine superfine active powder buccal tablet surplus is an adjuvant, and adjuvant is routine (can determine according to processing technique).
Among the present invention, described Chinese medicine superfine active micropowder can be health-related Chinese medicine superfine active micropowder, for example: Radix Panacis Quinquefolii superfine active micropowder, Ganoderma superfine active micropowder, Cornu Cervi Pantotrichum superfine active micropowder, Margarita superfine active micropowder, Cordyceps superfine active micropowder, Radix Ginseng superfine active micropowder or above product mixture, more than be enumerated as the common types of drugs in this area, certainly should not constitute restriction of the present invention with this, other drug kind such as Fructus Lycii, Fructus Schisandrae Chinensis etc. also can be used as medicine and be continued to use preparation method of the present invention and make buccal tablet.
Among the present invention, described Chinese medicine superfine active powder buccal tablet can be Radix Panacis Quinquefolii superfine active powder buccal tablet.Radix Panacis Quinquefolii superfine active powder content is 20%-60% in the described Radix Panacis Quinquefolii superfine active powder buccal tablet, is preferably 35%-45%, more preferably 40%.
Among the present invention, described Chinese medicine superfine active powder buccal tablet can be Ganoderma superfine active powder buccal tablet.Ganoderma superfine active powder content is 20%-60% in the described Ganoderma superfine active powder buccal tablet, is preferably 35%-45%, more preferably 40%.
Among the present invention, described Chinese medicine superfine active powder buccal tablet can be Margarita superfine active powder buccal tablet.Margarita superfine active powder content is 20%-60% in the described Margarita superfine active powder buccal tablet, is preferably 35%-45%, more preferably 40%.
Among the present invention, described Chinese medicine superfine active powder buccal tablet can be Cordyceps superfine active powder buccal tablet.Cordyceps superfine active powder content is 20%-60% in the described Cordyceps superfine active powder buccal tablet, is preferably 35%-45%, more preferably 40%.
Among the present invention, described adjuvant is conventional adjuvant, and the selection of this adjuvant is decided by the processing technology thereof of described Chinese medicine superfine active powder buccal tablet, for the ordinary skill in the art, if determined processing technique, then corresponding adjuvant kind and proportioning thereof can be determined.The vitamins that couple human body beneficial also can be arranged in the adjuvant; Also can adjust the corresponding proportion of relevant adjuvant, improve the framing structure of buccal tablet, strengthen the slow-release function of buccal tablet.Described adjuvant can be selected from microcrystalline Cellulose, mannitol, dextrin, magnesium stearate, cane sugar powder, starch, pigment, essence, vitamin B, vitamin C, vitamin E etc.
The present invention also provides a kind of preparation method of Chinese medicine superfine active powder buccal tablet, and its technical process is as follows:
Earlier Chinese crude drug is crushed to 100 orders, further is crushed to again below the 10 μ m, under the controllable conventional temperature conditions of technical staff, or preferred temperature is 50-60 ℃, behind the vacuum drying, again gained Chinese medicine superfine active micropowder is mixed with adjuvant, then compound is directly adopted the compressing dry granulation molding.
The present invention also provides a kind of preparation method of Chinese medicine superfine active powder buccal tablet, and its technical process is as follows:
Earlier Chinese crude drug is crushed to 100 orders, further is crushed to again below the 10 μ m, in the adjuvant of gained Chinese medicine superfine active micropowder adding, when being cooled to adiabatic condensation temperature, inject the further cooling forming in compression bed cave that scribbles light liquid petrolatum or starch through dissolving.
Advantage of the present invention and effect are:
1, the active ingredient that contains in this Chinese medicine superfine active powder buccal tablet is the following Chinese medicine superfine active micropowders of 10 μ m, has and experiment showed, that other product specific surface area of this particle size fraction is big, biological activity is high, and easier is absorption of human body;
2, with the form administration of buccal tablet, made full use of the Absorption of oral mucosa to medicine, existing capsule class product only absorbs by gastrointestinal, has increased the absorption link of medicine, helps improving the drug absorption rate;
3, the active ingredient in the buccal tablet enters gastrointestinal again and further fully digests and assimilates after the enzyme effect of oral cavity saliva, reduces the harmful effect of gastro-intestinal Fluid pH to drug absorption on the one hand, has accelerated Absorption on the other hand, has improved medicine usefulness;
4, the active ingredient in the buccal tablet-superfine active micropowder is the active Chinese patent medicine superfine active micropowder that directly obtains through ultrafine grinding process, in the course of processing active ingredient loss less, preparation technology is simple.
5, buccal tablet adopts different method for makings to change the buccal tablet framing structure by adjusting adjuvant content, thereby controls effectively or delay drug release (more than 25-45 minute), and evenly the efficacy of a drug is stablized drug effect.
6, adopting the buccal tablet form is deep development to the Chinese medicine resource, the type product taking convenience, no residue, is convenient to preserve the adaptation modern life rhythm;
Clinic study shows: Radix Panacis Quinquefolii tool lung benefiting the moon, clear asthenic fire effect, brain is had sedation, nerve centre is had the excitation of moderate, can enhancing body to the specificity defence capability of various destructive stimuluses, have antifatigue effect.Radix Panacis Quinquefolii can the human body immunity improving function.Total panaquilon has enhancing body to anoxybiotic tolerance.The ascorbic reduction of rat that total panaquilon can obviously cause ACTH, and can reduce the mouse thymus that ACTH causes and the atrophy of spleen.Relevant experiment shows that also Radix Panacis Quinquefolii can reduce high fat mice blood middle cholesterol content, the myocardium acute ischemia state of protection isoproterenol induced mice.Cerebral tissue function antagonism central inhibitory action in protection mice hypobaric hypoxia and the acute ischemia.
Fig. 1 is the schematic flow sheet of Chinese medicine superfine active powder buccal tablet administration process of the present invention.
Now by reference to the accompanying drawings the present invention is described in detail as follows:
The approach that this lozenge acts on human body as shown in Figure 1, Chinese medicine superfine active micro mist is inlet port at first The chamber, by mouth cavity liquid digest and decompose such as salivas, the part effective ingredient can absorb by oral mucosa (faces Bed studies confirm that) directly enter the body circulation, the effective ingredient of lozenge further enters gastronintestinal system, Can absorb a part of effective ingredient again, can only be digested and assimilated by gastronintestinal system with respect to the capsule class product Single channel, increased a link of digesting and assimilating, it is little to improve preferably the Chinese medicine superfine active The comprehensive absorptivity of powder.
This kind drug effect mode has broken through the in the past mode of administration of super fine preparation, takes full advantage of mouth The absorption function of transmucosal with one " two-way simultaneous absorption system " of the common structure of stomach and intestine, has improved The absorptivity of human body super fine, relevant contrast and experiment shows that this product produces with respect to capsule class Product improve absorptivity 2-5%.
This product is used for poor appetite, insomnia, phychasthnia, anaemia etc.
Below be relevant specific product of the present invention and preparation method thereof embodiment, be beneficial to understand better the present invention, but the embodiment that is addressed not be the restriction of formation to protection scope of the present invention.
Embodiment 1:
Radix Panacis Quinquefolii superfine active powder buccal tablet (dry process) prescription is: Radix Panacis Quinquefolii superfine active micropowder 40 weight %, microcrystalline Cellulose 46 weight %, mannitol 11 weight %, dextrin 1.5 weight %, magnesium stearate (dispersant) 0.5 weight %, surplus is spice, Icing Sugar and pigment.
Preparation process following (dry process method):
1, use conventional disintegrating apparatus that Chinese crude drug is crushed to 100 orders, the gained material is again through airflow milling
Further below superfine grinding to the 10 μ m;
2, vacuum drying when 55 ℃ of left and right sides;
3, gained Chinese medicine superfine active micropowder is mixed with adjuvant;
4, compound is directly adopted the compressing dry granulation molding;
5, monolithic bubble-cap formula packaging product.
Embodiment 2:
Radix Panacis Quinquefolii superfine active powder buccal tablet (dry process, preparation method is the same, the vacuum drying temperature is about 52 ℃) and comprise Radix Panacis Quinquefolii superfine active micropowder 20 weight %, cane sugar powder 78.2 weight %, starch 1.2 weight %, magnesium stearate is a surplus.
Embodiment 3:
Ganoderma superfine active powder buccal tablet (dry process, preparation method is the same) comprises Ganoderma superfine active micropowder 40 weight %, and adjuvant content is with embodiment 1.
Embodiment 4:
(the dry process of Margarita superfine active powder buccal tablet, preparation method is the same) comprise Margarita superfine active micropowder 40 weight %, microcrystalline Cellulose 36 weight %, mannitol 9 weight %, dextrin 1.3 weight %, magnesium stearate (dispersant) 0.5 weight %, vitamin B 0.2 weight %, vitamin C 10 weight %, vitamin E2 weight %, surplus is spice, Icing Sugar and pigment.
Embodiment 5:
Cordyceps superfine active powder buccal tablet (dry process, preparation method is the same, the vacuum drying temperature is about 58 ℃) and comprising Cordyceps superfine active micropowder 40 weight %, adjuvant content is with embodiment 1.
Embodiment 6:
Radix Panacis Quinquefolii superfine active powder buccal tablet (mechanography preparation) comprises Radix Panacis Quinquefolii superfine active micropowder 60 weight %, glycerol 16 weight %, water 16 weight %, gelatin 8 weight %.
Preparation process (mechanography preparation method) is as follows:
1, use conventional disintegrating apparatus that Chinese crude drug is crushed to 100 orders, the gained material advances through airflow milling again
Below one step superfine grinding to the 10 μ m;
2, with in the adjuvant of gained Chinese medicine superfine active micropowder adding through dissolving;
3, be cooled to adiabatic condensation temperature;
4, inject the further cooling forming in compression bed cave that scribbles light liquid petrolatum or starch.
5, monolithic bubble-cap formula packaging product.
Embodiment 7:
Ganoderma superfine active powder buccal tablet (mechanography preparation, preparation process is the same) comprises Ganoderma superfine active micropowder 60 weight %, and adjuvant content is with embodiment 6.
Embodiment 8:
Margarita superfine active powder buccal tablet (mechanography preparation, preparation process is the same) comprises Margarita superfine active micropowder 60 weight %, and adjuvant content is with embodiment 6.
Embodiment 9:
Cordyceps superfine active powder buccal tablet (mechanography preparation, preparation process is the same) comprises Cordyceps superfine active micropowder 60 weight %, and adjuvant content is with embodiment 6.
Claims (10)
1, a kind of Chinese medicine superfine active powder buccal tablet is characterized in that: wherein contain the Chinese medicine superfine active micropowder of 15%-85 weight %, described Chinese medicine superfine active micropowder granularity is below 10 μ m, and surplus is an adjuvant.
2, Chinese medicine superfine active powder buccal tablet as claimed in claim 1 is characterized in that: described Chinese medicine superfine active micropowder is Radix Panacis Quinquefolii superfine active micropowder, Ganoderma superfine active micropowder, Cornu Cervi Pantotrichum superfine active micropowder, Radix Ginseng superfine active micropowder, Margarita superfine active micropowder, Cordyceps superfine active micropowder or above product mixture.
3, Chinese medicine superfine active powder buccal tablet as claimed in claim 2 is characterized in that: described Chinese medicine superfine active powder buccal tablet is a Radix Panacis Quinquefolii superfine active powder buccal tablet, and wherein Radix Panacis Quinquefolii superfine active powder content is 20%-60%.
4, Chinese medicine superfine active powder buccal tablet as claimed in claim 3 is characterized in that: Radix Panacis Quinquefolii superfine active powder content is 35%-45% in the described Radix Panacis Quinquefolii superfine active powder buccal tablet.
5, Chinese medicine superfine active powder buccal tablet as claimed in claim 2 is characterized in that: described Chinese medicine superfine active powder buccal tablet is a Ganoderma superfine active powder buccal tablet, and wherein Ganoderma superfine active powder content is 20%-60%.
6, Chinese medicine superfine active powder buccal tablet as claimed in claim 2 is characterized in that: described Chinese medicine superfine active powder buccal tablet is a Margarita superfine active powder buccal tablet, and wherein Margarita superfine active powder content is 20%-60%.
7, Chinese medicine superfine active powder buccal tablet as claimed in claim 2 is characterized in that: described Chinese medicine superfine active powder buccal tablet is a Cordyceps superfine active powder buccal tablet, and wherein Cordyceps superfine active powder content is 20%-60%.
8, as each described Chinese medicine superfine active powder buccal tablet among the claim 1-7, it is characterized in that: described adjuvant is selected from microcrystalline Cellulose, mannitol, dextrin, magnesium stearate, cane sugar powder, starch, pigment, essence, vitamin B, vitamin C, vitamin E etc.
9, a kind of preparation method of Chinese medicine superfine active powder buccal tablet is characterized in that: earlier Chinese crude drug is crushed to below the 10 μ m, behind the vacuum drying gained Chinese medicine superfine active micropowder is mixed with adjuvant, directly adopt the compressing dry granulation molding then.
10, a kind of preparation method of Chinese medicine superfine active powder buccal tablet is characterized in that: earlier Chinese crude drug is crushed to below the 10 μ m, gained Chinese medicine superfine active micropowder is sneaked in the liquid adjuvant, with conventional mechanography compression moulding.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00124586 CN1344539A (en) | 2000-09-22 | 2000-09-22 | Superfine active Chinese medicine powder buccal tablet and its making process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 00124586 CN1344539A (en) | 2000-09-22 | 2000-09-22 | Superfine active Chinese medicine powder buccal tablet and its making process |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1344539A true CN1344539A (en) | 2002-04-17 |
Family
ID=4590521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 00124586 Pending CN1344539A (en) | 2000-09-22 | 2000-09-22 | Superfine active Chinese medicine powder buccal tablet and its making process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1344539A (en) |
Cited By (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100518746C (en) * | 2007-09-30 | 2009-07-29 | 张雪峰 | Aweto micropowder tablet and preparation method thereof |
| CN101018489B (en) * | 2004-09-15 | 2010-11-03 | Cj第一制糖株式会社 | A method preparing micron-size ginseng powder via the mechanical grindings |
| CN102406679A (en) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | Traditional Chinese medicine American ginseng buccal tablet |
| CN102512459A (en) * | 2011-12-15 | 2012-06-27 | 浙江大学 | Preparation method and use for pollution-free ganoderma lucidum ultrafine powder |
| CN102742838A (en) * | 2011-07-11 | 2012-10-24 | 张雪峰 | Preparation method of Chinese caterpillar fungus freeze-dried buccal tablet |
| CN103099824A (en) * | 2012-12-10 | 2013-05-15 | 天马（安徽）中药饮片科技有限公司 | Cordyceps sinensis ultra-fine powder buccal tablet |
| CN103099210A (en) * | 2012-08-29 | 2013-05-15 | 江门市新会区光华生物科技有限公司 | Polygonum multiflorum nutrient tablet and making method thereof |
| CN103251654A (en) * | 2013-05-16 | 2013-08-21 | 汤臣倍健股份有限公司 | Pearl powder vitamin C and E capsule and preparation method thereof |
| CN103652846A (en) * | 2012-09-25 | 2014-03-26 | 江苏学府生物工程有限公司 | Production method for cordyceps militaris buccal tablets |
| CN103783531A (en) * | 2014-03-04 | 2014-05-14 | 吉林大学 | Ultra-micro ginseng pearl powder tablet and production technology thereof |
| CN104642688A (en) * | 2015-02-13 | 2015-05-27 | 佛山市宝资林生物科技有限公司 | Preparation method of cordyceps militaris link tableted candy |
| CN104872365A (en) * | 2015-06-19 | 2015-09-02 | 陈政 | Tartary buckwheat dextrose candy and making method thereof |
| CN104887831A (en) * | 2015-06-19 | 2015-09-09 | 陈政 | Traditional Chinese medicine pressed candy and preparation method thereof |
| CN104920753A (en) * | 2015-06-19 | 2015-09-23 | 陈政 | Traditional Chinese medicine tabletting candy and preparation method thereof |
| CN105534934A (en) * | 2016-02-11 | 2016-05-04 | 罗建华 | Buccal tablet containing isaria cicadae miq and corn cervi pantotrichum and preparation method thereof |
| CN106465932A (en) * | 2016-03-15 | 2017-03-01 | 曾建平 | The compound method of Cordycepses Fructus Lycii buccal tablet |
| CN106626496A (en) * | 2017-02-27 | 2017-05-10 | 天津橘井科技有限公司 | Traditional Chinese medicine fine powder compression mold forming technique |
| CN106619734A (en) * | 2016-12-15 | 2017-05-10 | 湖南中健欣元生物科技有限公司 | Royal jelly pellet lozenge and preparation method thereof |
-
2000
- 2000-09-22 CN CN 00124586 patent/CN1344539A/en active Pending
Cited By (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101018489B (en) * | 2004-09-15 | 2010-11-03 | Cj第一制糖株式会社 | A method preparing micron-size ginseng powder via the mechanical grindings |
| CN100518746C (en) * | 2007-09-30 | 2009-07-29 | 张雪峰 | Aweto micropowder tablet and preparation method thereof |
| CN102742838A (en) * | 2011-07-11 | 2012-10-24 | 张雪峰 | Preparation method of Chinese caterpillar fungus freeze-dried buccal tablet |
| CN102406679A (en) * | 2011-11-30 | 2012-04-11 | 中山市中智药业集团有限公司 | Traditional Chinese medicine American ginseng buccal tablet |
| CN102406679B (en) * | 2011-11-30 | 2014-03-26 | 中山市中智药业集团有限公司 | Traditional Chinese medicine American ginseng buccal tablet |
| CN102512459A (en) * | 2011-12-15 | 2012-06-27 | 浙江大学 | Preparation method and use for pollution-free ganoderma lucidum ultrafine powder |
| CN103099210B (en) * | 2012-08-29 | 2014-08-13 | 江门市新会区光华生物科技有限公司 | Polygonum multiflorum nutrient tablet and making method thereof |
| CN103099210A (en) * | 2012-08-29 | 2013-05-15 | 江门市新会区光华生物科技有限公司 | Polygonum multiflorum nutrient tablet and making method thereof |
| CN103652846A (en) * | 2012-09-25 | 2014-03-26 | 江苏学府生物工程有限公司 | Production method for cordyceps militaris buccal tablets |
| CN103099824A (en) * | 2012-12-10 | 2013-05-15 | 天马（安徽）中药饮片科技有限公司 | Cordyceps sinensis ultra-fine powder buccal tablet |
| CN103251654A (en) * | 2013-05-16 | 2013-08-21 | 汤臣倍健股份有限公司 | Pearl powder vitamin C and E capsule and preparation method thereof |
| CN103783531A (en) * | 2014-03-04 | 2014-05-14 | 吉林大学 | Ultra-micro ginseng pearl powder tablet and production technology thereof |
| CN104642688A (en) * | 2015-02-13 | 2015-05-27 | 佛山市宝资林生物科技有限公司 | Preparation method of cordyceps militaris link tableted candy |
| CN104872365A (en) * | 2015-06-19 | 2015-09-02 | 陈政 | Tartary buckwheat dextrose candy and making method thereof |
| CN104887831A (en) * | 2015-06-19 | 2015-09-09 | 陈政 | Traditional Chinese medicine pressed candy and preparation method thereof |
| CN104920753A (en) * | 2015-06-19 | 2015-09-23 | 陈政 | Traditional Chinese medicine tabletting candy and preparation method thereof |
| CN105534934A (en) * | 2016-02-11 | 2016-05-04 | 罗建华 | Buccal tablet containing isaria cicadae miq and corn cervi pantotrichum and preparation method thereof |
| CN106465932A (en) * | 2016-03-15 | 2017-03-01 | 曾建平 | The compound method of Cordycepses Fructus Lycii buccal tablet |
| CN106619734A (en) * | 2016-12-15 | 2017-05-10 | 湖南中健欣元生物科技有限公司 | Royal jelly pellet lozenge and preparation method thereof |
| CN106619734B (en) * | 2016-12-15 | 2019-09-03 | 湖南中健欣元生物科技有限公司 | A kind of royal jelly pellet lozenge and preparation method thereof |
| CN106626496A (en) * | 2017-02-27 | 2017-05-10 | 天津橘井科技有限公司 | Traditional Chinese medicine fine powder compression mold forming technique |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1344539A (en) | Superfine active Chinese medicine powder buccal tablet and its making process | |
| CN1857618A (en) | Chinese medicine preparation for reducing sugar | |
| CN1765392A (en) | Chinese compound formulation for nourishing blood, regulating menstruation, stopping bleeding to prevent abortion and preparation method thereof | |
| CN1640488A (en) | Method for preparing supermicro powder preparation of cordyceps sinensis mycelium | |
| CN101007071A (en) | Traditional Chinese medicine for treating acute and chronic gastroenteritis and bacterial dysentery and its processing technology | |
| CN1813827A (en) | Sea-buckthorn chewing tablet and its preparation | |
| CN1471845A (en) | Healthy food with glossy and rhizoma as main material and preparing method thereof | |
| CN1927279A (en) | Chinese medicine composition for treating skin disease | |
| CN1215071C (en) | Erigeron ester B and its preparation method as well as application in pharmacy | |
| CN1733100A (en) | Chinese medicinal preparation for strengthening bone and generating blood and process for preparing the same | |
| CN1565467A (en) | Use of cornel and its extract in preparation alpha-glucosidase inhibitor medicine | |
| CN1765404A (en) | Chinese medicinal formulation for nourishing liver and improving eyesight and its preparation method | |
| CN1237994C (en) | Medicine composition for preparing canker and preparing method thereof | |
| CN1843418A (en) | Traditional Chinese medicine extract for treating gastroenteritis and traditional Chinese medicine composition containing same | |
| CN1820773A (en) | Chinese medicine composition for treating oral inflammation and its preparation | |
| CN1491715A (en) | Chewing tablet of fleece-flower root and preparing method | |
| CN1193769C (en) | Health-care food with sobering function | |
| CN109893603A (en) | It is a kind of to improve the composition of men's health, preparation method and applications | |
| CN1593398A (en) | Daidzein dispersible tablet composition and its preparation process | |
| CN1857373A (en) | Tranquilizing Chinese medicine composition and its preparing method and application | |
| CN1053818C (en) | Ulcer powder | |
| CN1259938C (en) | Chinese medicine compound preparation for treating cough and its preparing method | |
| CN1931296A (en) | Pinellia tuber extract and its prepn process, medicine composition and use | |
| CN1876075A (en) | A medicine for treating asthma, acute and chronic bronchitis and preparation method thereof | |
| CN100551383C (en) | The cardiopathic Chinese medicine preparation of a kind of treatment |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |